ImmunoGen, Inc.: Company Profile and SWOT Analysis

Document Sample
ImmunoGen, Inc.: Company Profile and SWOT Analysis Powered By Docstoc
					ImmunoGen, Inc.

_________________________________________________________________________________



ImmunoGen, Inc.                                                              Financial Snapshot

                                                                             Operating Performance
Fast Facts
                                     128 Sidney Street, Cambridge,           The company reported revenues of US$19.31 million
Headquarters Address
                                     02139,United States of America          during 2011, with a CAGR of -15.69% during 2007–
                                                                             2011. Its revenue grew at an annual rate of 38.46%
Telephone                            + 1 617 9952500
                                                                             over the previous fiscal year. In 2011, the company
                                                                             recorded an operating margin of -311.77%, as against
Fax                                  + 1 617 9952510                         -367.46% in 2010.

Website                              www.immunogen.com
                                                                             Revenue and Margins
Ticker Symbol, Stock Exchange        IMGN, NASDAQ

Number of Employees                  211

Fiscal Year End                      June

Revenue (in US$ million)             19.31




SWOT Analysis

Strengths                            Weaknesses

Proprietary TAP Technology           Declining Operating Margin

                                     Sanofi-Aventis: Discontinued Clinical
Significant Partnerships
                                     Trials

Opportunities                        Threats

Changing Demographics                Competitive Pressures

Growth in the Prevalence of Cancer   Uncertain R&D Outcomes

Sanofi-Aventis Expands Licenses to
TAP Technology




___________________________________________________________________________________________

ImmunoGen, Inc. - SWOT Profile                                                                                     Page 1
ImmunoGen, Inc.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
    2.3       Key Competitors ...................................................................................................................................................12
3     Mergers & Acquisitions and Partnerships ........................................................................................... 13
    3.1       M&A and Partnerships Strategy ...........................................................................................................................13
4     Recent Developments ........................................................................................................................... 15
5     SWOT Analysis ...................................................................................................................................... 17
    5.1       SWOT Analysis - Overview ..................................................................................................................................17
    5.2       Strengths ..............................................................................................................................................................17
    5.3       Weaknesses .........................................................................................................................................................17
    5.4       Opportunities ........................................................................................................................................................17
    5.5       Threats .................................................................................................................................................................18
6     ImmunoGen, Inc. - Company Statement .............................................................................................. 19
7     History .................................................................................................................................................... 22
8     ImmunoGen, Inc. - Key Employees ...................................................................................................... 24
9     Key Employee Biographies................................................................................................................... 25
10    Locations and Subsidiaries .................................................................................................................. 26
    10.1      Head Office ..........................................................................................................................................................26
    10.2      Other Locations and Subsidiaries ........................................................................................................................26
11    Appendix ................................................................................................................................................ 27
    11.1      Methodology .........................................................................................................................................................27
    11.2      Ratio Definitions ...................................................................................................................................................27
    11.3      Disclaimer.............................................................................................................................................................31




___________________________________________________________________________________________

ImmunoGen, Inc. - SWOT Profile                                                                                                                                              Page 2
ImmunoGen, Inc.

__________________________________________________________________________________________



List of Tables

Table 1: Major Products and Services ..................................................................................................................................6
Table 2: Key Ratios - Annual ..................................................................................................................................................7
Table 3: Key Ratios - Interim ..................................................................................................................................................9
Table 4: Key Capital Market Indicators ..................................................................................................................................9
Table 5: ImmunoGen, Inc., History .......................................................................................................................................22
Table 6: ImmunoGen, Inc., Key Employees .........................................................................................................................24
Table 7: Key Employee Biographies ....................................................................................................................................25
Table 8: ImmunoGen, Inc., Locations ..................................................................................................................................26




___________________________________________________________________________________________

ImmunoGen, Inc. - SWOT Profile                                                                                                                                       Page 3
ImmunoGen, Inc.

__________________________________________________________________________________________


List of Figures



Figure 1: Revenue and Operating Profit ...............................................................................................................................10
Figure 2: Financial Position ..................................................................................................................................................11




___________________________________________________________________________________________

ImmunoGen, Inc. - SWOT Profile                                                         
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "ImmunoGen, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.